GPX3 and breast carcinoma: In conclusion, our finding showed that GPX3 reduced expression was significantly correlated with number of metastatic lymph nodes, no distant metastasis, and nonhormone usage of breast cancer patients; this finding suggested that GPX3 plays an important role in breast carcinogenesis, and might serve as a prognostic biomarker in breast cancer patients.